Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) closed the day trading at $4.64 down -1.69% from the previous closing price of $4.72. In other words, the price has decreased by -$1.69 from its previous closing price. On the day, 0.52 million shares were traded. OLMA stock price reached its highest trading level at $4.825 during the session, while it also had its lowest trading level at $4.57.
Ratios:
For a better understanding of OLMA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 15.22 and its Current Ratio is at 15.22. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on April 02, 2024, initiated with a Buy rating and assigned the stock a target price of $24.
On January 30, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $20.
On July 21, 2023, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $21.Oppenheimer initiated its Outperform rating on July 21, 2023, with a $21 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 08 ’25 when Bain Capital Life Sciences Inv bought 300,000 shares for $5.76 per share. The transaction valued at 1,727,370 led to the insider holds 7,800,000 shares of the business.
Graham G. Walmsley sold 700,761 shares of OLMA for $4,730,137 on Dec 17 ’24. The Director now owns 0 shares after completing the transaction at $6.75 per share. On Dec 13 ’24, another insider, Logos Opportunities Fund I LP, who serves as the Affiliate of the company, bought 700,761 shares for $6.75 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OLMA now has a Market Capitalization of 317474816 and an Enterprise Value of -74084272.
Stock Price History:
The Beta on a monthly basis for OLMA is 1.93, which has changed by -0.6196721 over the last 52 weeks, in comparison to a change of 0.19554341 over the same period for the S&P500. Over the past 52 weeks, OLMA has reached a high of $13.93, while it has fallen to a 52-week low of $2.86. The 50-Day Moving Average of the stock is 0.94%, while the 200-Day Moving Average is calculated to be -21.76%.
Shares Statistics:
Over the past 3-months, OLMA traded about 685.98K shares per day on average, while over the past 10 days, OLMA traded about 556510 shares per day. A total of 68.33M shares are outstanding, with a floating share count of 52.12M. Insiders hold about 23.83% of the company’s shares, while institutions hold 78.41% stake in the company. Shares short for OLMA as of 1752537600 were 7638452 with a Short Ratio of 11.14, compared to 1749772800 on 6700924. Therefore, it implies a Short% of Shares Outstanding of 7638452 and a Short% of Float of 12.29.
Earnings Estimates
Investors are keenly observing as 6.0 analysts analyze and rate the current performance of Olema Pharmaceuticals Inc (OLMA) in the stock market.The consensus estimate for the next quarter is -$0.49, with high estimates of -$0.39 and low estimates of -$0.82.
Analysts are recommending an EPS of between -$1.53 and -$3.03 for the fiscal current year, implying an average EPS of -$1.9. EPS for the following year is -$2.23, with 6.0 analysts recommending between -$1.42 and -$3.86.
